Synopsis of recent research by authors named "Guido Groenen"
- Guido Groenen's research primarily focuses on tuberculosis (TB), particularly its resistant forms such as rifampicin-resistant (RR-TB) and extensively drug-resistant (XDR-TB), assessing treatment options and epidemiological trends.
- His findings highlight the potential efficacy of rifabutin for treating RR-TB and emphasize the concerning rise of XDR-TB in Belgium over a 15-year period, particularly among foreign-born individuals.
- Additionally, Groenen's molecular epidemiology studies in Brussels reveal significant differences in TB incidence rates and strain diversity, further informing public health strategies and treatment protocols in high-incidence areas.